Paul Edward Kelly - 03 Jan 2022 Form 4 Insider Report for RELMADA THERAPEUTICS, INC. (RLMD)

Role
Director
Signature
/s/ Paul E. Kelly
Issuer symbol
RLMD
Transactions as of
03 Jan 2022
Net transactions value
-$64,800
Form type
4
Filing time
05 Jan 2022, 16:01:08 UTC
Previous filing
21 Dec 2021
Next filing
05 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLMD Common Stock Options Exercise $64,800 -20,000 -9.6% $3.24 187,295 03 Jan 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RLMD Options to purchase common stock Options Exercise $0 -20,000 -40% $0.000000 30,500 03 Jan 2022 Common Stock 20,000 $3.24 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest from the date of grant in equal quarterly increments of 6.25% over a four year period.
F2 Not applicable.